A Phase III Clinical Study to Evaluate the Efficacy and Safety of GZR18 Injection in Subjects With Type 2 Diabetes Mellitus and Poor Blood Glucose Control by Diet and Exercise
Clinical trial NCT06777238 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT06777238
- Sponsor
- Gan & Lee Pharmaceuticals.
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2025-01-16
- Primary completion
- 2026-08-07
- Enrollment
- 274
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.